Immunome Inc (IMNM) support and resistance · $2.47B cap
Immunome Inc (IMNM) is a biotechnology company listed on US.
This page maps Immunome Inc (IMNM) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
IMNM currently screens at market cap $2.47B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IMNM 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IMNM quote page for the session range and the stock page for the full model.
Not investment advice.